OverviewSuggest Edit

Johnson & Johnson is a global holding company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company operates in three business segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes a range of products used in baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets. The Pharmaceutical segment is focused on the therapeutic areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolism, as well as pulmonary hypertension. The Medical Devices segment includes a range of products used in the orthopedic, surgery, interventional solutions, and eye health fields.

Its major brands include:

TypePublic
Founded1886
HQNew Brunswick, NJ, US
Websitejnj.com
Employee Ratings4.2
Overall CultureC

Latest Updates

Employees (est.) (Jan 2021)134,500(+2%)
Job Openings3,842
Revenue (FY, 2019)$82.1 B
Share Price (Sept 2021)$165.4
Cybersecurity ratingCMore

Key People/Management at Johnson & Johnson

Alex Gorsky

Alex Gorsky

Chairman, Board of Directors and Chief Executive Officer
Joaquin Duato

Joaquin Duato

Vice Chairman of the Executive Committee
Peter Fasolo

Peter Fasolo

Executive Vice President, Chief Human Resources Officer
Thibaut Mongon

Thibaut Mongon

Executive Vice President, Worldwide Chairman, Consumer Health
Ashley McEvoy

Ashley McEvoy

Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson
Paul Stoffels

Paul Stoffels

Vice Chairman of the Executive Committee and Chief Scientific Officer
Show more

Johnson & Johnson Office Locations

Johnson & Johnson has offices in New Brunswick, Jacksonville, Lancaster, Piscataway and in 52 other locations
New Brunswick, NJ, US (HQ)
1 Johnson And Johnson Plaza
Jacksonville, FL, US
7500 Centurion Pkwy N
Lancaster, PA, US
1838 Colonial Village Ln
Piscataway, NJ, US
425 NJ-18
Buenos Aires, AR
Mendoza 1259
Chippendale, AU
5 Broadway
Show all (57)

Johnson & Johnson Financials and Metrics

Johnson & Johnson Revenue

Embed Graph
View revenue for all periods
Johnson & Johnson's revenue was reported to be $82.06 b in FY, 2019 which is a 0.6% increase from the previous period.
USD

Revenue (Q3, 2020)

21.1b

Gross profit (Q3, 2020)

14.1b

Gross profit margin (Q3, 2020), %

66.9%

Net income (Q3, 2020)

3.6b

Market capitalization (15-Sept-2021)

435.6b

Closing stock price (15-Sept-2021)

165.4

Cash (27-Sept-2020)

19.0b

EV

454.4b
Johnson & Johnson's current market capitalization is $435.6 b.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

76.5b81.6b82.1b

Revenue growth, %

6%7%1%

Cost of goods sold

25.4b27.1b27.6b

Gross profit

51.1b54.5b54.5b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

17.8b18.8b19.7b20.0b20.8b20.3b20.0b20.6b20.7b20.7b18.3b21.1b

Cost of goods sold

5.4b5.8b6.9b6.6b6.9b6.6b6.6b6.9b6.9b7.1b6.6b7.0b

Gross profit

12.4b13.0b12.7b13.4b13.9b13.8b13.4b13.6b13.9b13.6b11.8b14.1b

Gross profit Margin, %

70%69%65%67%67%68%67%66%67%66%64%67%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

17.8b18.1b17.3b

Accounts Receivable

13.5b14.1b14.5b

Prepaid Expenses

2.5b2.7b2.4b

Inventories

8.8b8.6b9.0b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

20.9b12.6b15.7b14.6b17.6b16.1b14.7b14.4b16.2b15.5b11.2b19.0b

Accounts Receivable

12.3b13.3b13.2b14.2b14.1b14.0b14.1b14.7b14.8b14.9b14.6b14.6b

Prepaid Expenses

2.8b3.0b2.9b2.6b2.6b2.9b2.6b2.4b2.2b2.4b2.6b2.5b

Inventories

8.9b9.7b9.5b9.0b8.8b8.7b9.1b9.3b9.2b8.9b9.4b9.6b
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

1.3b15.3b15.1b

Depreciation and Amortization

5.6b6.9b7.0b

Inventories

581.0m(644.0m)(277.0m)

Accounts Payable

2.7b4.0b4.1b
USDQ1, 2018

Debt/Equity

0.5 x

Debt/Assets

0.2 x

Financial Leverage

2.1 x
Show all financial metrics

Johnson & Johnson Operating Metrics

FY, 2016FY, 2017Jun, 2018FY, 2018FY, 2019

Manufacturing Facilities

11912511197

Countries

606060

Distribution Centers

350

Suppliers

3.5 k
Show all operating metrics

Johnson & Johnson Acquisitions / Subsidiaries

Company NameDateDeal Size
Momenta PharmaceuticalsAugust 19, 2020$6.5 b
TARIS BiomedicalDecember 20, 2019
Verb SurgicalDecember 20, 2019
Auris HealthJanuary 23, 2019$3.4 b
Ci:z HoldingsOctober 23, 2018$2.1 b
Zarbee's NaturalsJuly 27, 2018
OrthotaxyFebruary 20, 2018
Actelion PharmaceuticalsJanuary 26, 2017$30 b
Abott Medical OpticsSeptember 16, 2016$4.33 b
Vogue InternationalJune 02, 2016$3.3 b
Show more

Johnson & Johnson Revenue Breakdown

Embed Graph

Johnson & Johnson revenue breakdown by business segment: 31.6% from Medical Devices, 51.4% from Pharmaceutical and 16.9% from Consumer

Johnson & Johnson revenue breakdown by geographic segment: 19.0% from Asia-Pacific, Africa, 7.2% from Western Hemisphere excluding US, 22.5% from Europe and 51.3% from United States

Human Capital Metrics

Embed Graph
Show all human capital metrics

Johnson & Johnson Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

Johnson & Johnson Online and Social Media Presence

Embed Graph

Johnson & Johnson Company Culture

  • Overall Culture

    C

    71/100

  • CEO Rating

    D

    62/100

  • Compensation

    D

    54/100

Learn more on Comparably

Johnson & Johnson News and Updates

Will Johnson & Johnson Stock Rebound After A 4% Fall In A Week?

The stock price of Johnson & Johnson reached its all-time high of around $180 just last month before a recent sell-off in pharmaceutical stocks resulted in JNJ falling to $165 levels currently. Last month, we discussed that based on historical performance, there were higher chances of a decline.…

FDA authorizes additional Johnson & Johnson batches from Baltimore facility

FDA authorizes additional Johnson & Johnson batches from Baltimore facility

Relative Strength Alert For Johnson & Johnson

But making Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of JNJ entered into oversold territory, changing hands as low as $165.67 per share.

Moderna More Effective Against Delta Than Pfizer and Johnson & Johnson

COVID-19 vaccines are effective at preventing hospitalizations and emergency department visits caused by the Delta variant, according to data from a national study. That data also indicate that Moderna’s vaccine is significantly more effective against Delta than Pfizer and Johnson & Johnson.  

Fact check : Pfizer , Moderna and Johnson & Johnson COVID - 19 vaccines all passed animal testing

Fact check : Pfizer , Moderna and Johnson & Johnson COVID - 19 vaccines all passed animal testing

Suit alleges Johnson & Johnson warehouse worker faced racial slurs , threats

Suit alleges Johnson & Johnson warehouse worker faced racial slurs , threats
Show more

Johnson & Johnson Blogs

Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases

Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases Brian.Hoenig@n… Tue, 09/14/2021 - 08:17 Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune …

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress Liz.McPherson@… Wed, 09/08/2021 - 10:19 Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress …
Show more

Johnson & Johnson Frequently Asked Questions

  • When was Johnson & Johnson founded?

    Johnson & Johnson was founded in 1886.

  • Who are Johnson & Johnson key executives?

    Johnson & Johnson's key executives are Alex Gorsky, Joaquin Duato and Peter Fasolo.

  • How many employees does Johnson & Johnson have?

    Johnson & Johnson has 134,500 employees.

  • What is Johnson & Johnson revenue?

    Latest Johnson & Johnson annual revenue is $82.1 b.

  • What is Johnson & Johnson revenue per employee?

    Latest Johnson & Johnson revenue per employee is $610.1 k.

  • Who are Johnson & Johnson competitors?

    Competitors of Johnson & Johnson include Boston Scientific, GSK and Estee Lauder.

  • Where is Johnson & Johnson headquarters?

    Johnson & Johnson headquarters is located at 1 Johnson And Johnson Plaza, New Brunswick.

  • Where are Johnson & Johnson offices?

    Johnson & Johnson has offices in New Brunswick, Jacksonville, Lancaster, Piscataway and in 52 other locations.

  • How many offices does Johnson & Johnson have?

    Johnson & Johnson has 57 offices.